Patent US6447534B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6447534B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Device and method for facilitating hemostasis of a biopsy tract

Assignee: Boston Scientific Scimed Inc
•
Filing: 2001-03-13
•
Granted: 2002-09-10
•
Expires: 2021-03-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A system including an adaptor and a syringe is used for facilitating hemostasis of a biopsy tract or other puncture wound by delivery of an absorbable sponge in a hydrated state into the wound. The adaptor includes a tapered lumen for hydrating and compressing the relatively large absorbable sponge for delivery through a relatively small cannula, such as a biopsy needle. The hydrated absorbable sponge is injected through the biopsy needle into the biopsy tract by fluid. Alternatively, the sponge may be delivered to the biopsy needle by injection of fluid and then delivered to the biopsy tract by a plunger or stylet. The system may also include a trail staging chamber for inspecting a condition of the sponge before delivery. The implanted absorbable sponge facilitates hemostasis at the biopsy site or other puncture wound and minimizes the chance of internal bleeding. The absorbable sponge material is absorbed by the body over time.

Inventors

  • 👤 Andrew H. Cragg
  • 👤 Rodney Brenneman
  • 👤 Mark Ashby

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 20:46
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/0057; A61B10/00; A61B10/02; A61B10/0233; A61B2017/00004; A61B2017/00637; A61B2017/00646; A61B2017/00654

Claims Analysis

Total Claims: 39
Claim 1
Independent Claim 83 words
A method of delivering a hemostatic material for facilitating hemostasis of a puncture wound, the method comprising: inserting the hemostatic material having a continuous structure into an adapter; connecting the adapter to a trail staging chamber and injecting the hemostatic material from the adapter into the trail staging chamber to form a continuous trail of hemostatic material; connecting the trail staging chamber to a cannula; and delivering the continuous trail of hemostatic material through the cannula to facilitate hemostasis of the puncture wound.
Claim 2
Independent Claim 83 words
A method of delivering a hemostatic material for facilitating hemostasis of a puncture wound, the method comprising: inserting the hemostatic material having a continuous structure into an adapter; connecting the adapter to a trail staging chamber and injecting the hemostatic material from the adapter into the trail staging chamber to form a continuous trail of hemostatic material; connecting the trail staging chamber to a cannula; and delivering the continuous trail of hemostatic material through the cannula to facilitate hemostasis of the puncture wound.
Claim 3
Dependent Claim 28 words
The method according to claim 1 , further comprising a step of elongating the hemostatic material as it passes through the adapter and into the trail staging chamber.
Claim 4
Dependent Claim 33 words
The method according to claim 1 , further comprising connecting a removable vent cap to the trail staging chamber prior to injecting the hemostatic material from the adapter into the trail staging chamber.
Claim 5
Dependent Claim 27 words
The method according to claim 3 , further comprising a step of injecting a fluid until a distal end of the hemostatic material contacts the vent cap.
Claim 6
Dependent Claim 27 words
The method according to claim 4 , further comprising a step of expelling the hemostatic material if gaps or spaces are viewed in the trail staging chamber.
Claim 7
Dependent Claim 32 words
The method according to claim 5 , further comprising a step of expelling the hemostatic material by removing the vent cap, and injecting a new hemostatic material into the trail staging chamber.
Claim 8
Dependent Claim 25 words
The method according to claim 4 , further comprising a step of removing the vent cap and connecting the trail staging chamber to the cannula.
Claim 9
Dependent Claim 34 words
The method according to claim 1 , further comprising a step of delivering the continuous trail to a biopsy tract, wherein the cannula through which the hemostatic material is delivered is a biopsy needle.
Claim 10
Dependent Claim 20 words
The method according to claim 1 , further comprising a step of delivering the continuous trail to an arterial site.
Claim 11
Dependent Claim 14 words
The method according to claim 1 , wherein the trail staging chamber is transparent.
Claim 12
Dependent Claim 25 words
The method according to claim 1 , wherein the trail of hemostatic material is delivered to the puncture wound by a plunger within the cannula.
Claim 13
Dependent Claim 20 words
The method according to claim 11 , further comprising a step of delivering the hemostatic material by withdrawing the cannula.
Claim 14
Dependent Claim 20 words
The method according to claim 1 , wherein the hemostatic material is hydrated before delivery and expands rapidly upon delivery.
Claim 15
Dependent Claim 14 words
The method according to claim 1 , wherein the hemostatic material is mechanically stable.
Claim 16
Dependent Claim 18 words
The method according to claim 1 , where in the hemostatic material is a gelatin based sponge material.
Claim 17
Dependent Claim 18 words
The method according to claim 1 , wherein the hemostatic material is delivered for cosmetic or reconstructive bulking.
Claim 18
Dependent Claim 16 words
The method according to claim 1 , wherein the hemostatic material is delivered for intravascular embolization.
Claim 19
Dependent Claim 18 words
The method according to claim 1 , wherein the hemostatic material is used to deliver a beneficial agent.
Claim 20
Dependent Claim 18 words
The method according to claim 1 , wherein the hemostatic material is used to deliver a therapeutic agent.
Claim 21
Dependent Claim 17 words
The method according to claim 1 , wherein the hemostatic material having continuous structure is a sponge.
Claim 22
Independent Claim 62 words
A method of staging a pledget of a sponge in a cannula for delivery to a puncture would, the method comprising; inserting the pledget of a sponge into an adapter having a tapered lumen; and connecting the adapter to a trail staging chamber and injecting the pledget from the adapter into the trail staging chamber to form a continuous trail of pledget.
Claim 23
Independent Claim 62 words
A method of staging a pledget of a sponge in a cannula for delivery to a puncture would, the method comprising; inserting the pledget of a sponge into an adapter having a tapered lumen; and connecting the adapter to a trail staging chamber and injecting the pledget from the adapter into the trail staging chamber to form a continuous trail of pledget.
Claim 24
Dependent Claim 36 words
The method according to claim 1 , further comprising a step of: connecting the trail staging chamber to a cannula; and advancing the pledget into the cannula for delivery to the puncture wound to facilitate hemostasis.
Claim 25
Dependent Claim 28 words
The method according to claim 1 , further comprising a step of hydrating the pledget in the adapter before delivery of the pledget to the trail staging chamber.
Claim 26
Dependent Claim 20 words
The method according to claim 1 , further comprising a step of hydrating the pledget in the trail staging chamber.
Claim 27
Dependent Claim 23 words
The method according to claim 1 , further comprising a step of positioning the pledget in the trail staging chamber by fluid pressure.
Claim 28
Dependent Claim 21 words
The method according to claim 1 , further comprising a step of positioning the pledget within a transparent trail staging chamber.
Claim 29
Dependent Claim 20 words
The method according to claim 1 , further comprising a step of viewing the pledget in the trail staging chamber.
Claim 30
Dependent Claim 33 words
The method according to claim 1 , further comprising a step of positioning the pledget within the trail staging chamber using a removable vent cap configured to engage one end of the adapter.
Claim 31
Dependent Claim 23 words
The method according to claim 1 , further comprising a step of positioning the pledget within the trail staging chamber using a syringe.
Claim 32
Independent Claim 75 words
A method of delivering a continuous trail of hemostatic material for facilitating hemostasis of a puncture wound, the method comprising: delivering the hemostatic material having a continuous structure without gaps or spaces into a cannula with fluid pressure to form a continuous trail of sponge material; and delivering the continuous trail of hemostatic material from the cannula to the puncture wound while maintaining continuity of the hemostatic material to facilitate hemostasis of the puncture wound.
Claim 33
Independent Claim 75 words
A method of delivering a continuous trail of hemostatic material for facilitating hemostasis of a puncture wound, the method comprising: delivering the hemostatic material having a continuous structure without gaps or spaces into a cannula with fluid pressure to form a continuous trail of sponge material; and delivering the continuous trail of hemostatic material from the cannula to the puncture wound while maintaining continuity of the hemostatic material to facilitate hemostasis of the puncture wound.
Claim 34
Dependent Claim 22 words
The method of claim 30 , wherein the hemostatic material is delivered to the cannula from an adaptor having a tapered lumen.
Claim 35
Dependent Claim 25 words
The method of claim 30 , wherein the hemostatic material is delivered from the cannula to the puncture wound by a plunger within the cannula.
Claim 36
Dependent Claim 20 words
The method according to claim 30 , wherein the hemostatic material is hydrated before delivery and expands rapidly upon delivery.
Claim 37
Dependent Claim 14 words
The method according to claim 30 , wherein the hemostatic material is mechanically stable.
Claim 38
Dependent Claim 17 words
The method according to claim 30 , wherein the hemostatic material is a gelatin based sponge material.
Claim 39
Dependent Claim 14 words
The method according to claim 30 , wherein the hemostatic material is a sponge.

References Cited (Backward Citations)

US2899362A Cited
US581235A Cited
US1578517A Cited
US2086580A Cited
US2465357A Cited
US2492458A Cited
US2507244A Cited
US2558395A Cited
US2597011A Cited
US2680442A Cited
US2814294A Cited
US2824092A Cited
US2761446A Cited
US3157524A Cited
GB1509023A Cited
US4000741A Cited
GB1569660A Cited
US4588395A Cited
US4900303A Cited
US4323072A Cited
EP0032826B1 Cited
US4340066A Cited
US4390018A Cited
US4645488A Cited
US4515637A Cited
US4619913A Cited
US4619261A Cited
US4587969A Cited
US4708718A Cited
US4852568A Cited
US4744364A Cited
US4890612A Cited
US4950234A Cited
US4829994A Cited
US4850960A Cited
US4790819A Cited
US5080655A Cited
US4936835A Cited
US5195988A Cited
US5053046A Cited
US4929246A Cited
US5192301A Cited
FR2641692B1 Cited
US5007895A Cited
US5242683A Cited
US5061274A Cited
US5021059A Cited
US5391183A Cited
US5591204A Cited
US5725498A Cited
EP0482350B1 Cited
US5437631A Cited
US5741223A Cited
US5830130A Cited
EP0476178A1 Cited
US5275616A Cited
US5601602A Cited
US5275616B1 Cited
US5192300A Cited
US5108421A Cited
US5478352A Cited
US5716375A Cited
US5591205A Cited
US5167624A Cited
US5366480A Cited
US5221259A Cited
US5419765A Cited
US5310407A Cited
US5163904A Cited
US5220926A Cited
US5540715A Cited
US5334216A Cited
US5558853A Cited
US5370656A Cited
US5322515A Cited
US5467780A Cited
US5388588A Cited
US5479936A Cited
US5383896A Cited
US5325857A Cited
US5486195A Cited
US5431639A Cited
US5653730A Cited
US5529577A Cited
US5383899A Cited
US5665107A Cited
US5775333A Cited
US5649547A Cited
US5526822A Cited
US5385550A Cited
US5545178A Cited
US5522850A Cited
US6027482A Cited
US6027471A Cited
US5645566A Cited
US5769086A Cited
US5800389A Cited
US5902310A Cited
US5810806A Cited
US5681279A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2005-09-09 2006-03-11 2006-09-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2009-09-09 2010-03-11 2010-09-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2013-09-09 2014-03-11 2014-09-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag